Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
T-prolymphocytic leukemia (T-PLL) has a very poor prognosis with conventional immunochemotherapy. Incidental reports suggest that allogeneic hematopoietic stem cell transplantation (allo-HSCT) might have a role in this disease. Therefore, the purpose of the present study was to analyze the outcome o...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Leukemia
Year: 2011, Jahrgang: 26, Heft: 5, Pages: 972-976 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2011.304 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/leu.2011.304 Verlag, Volltext: https://www.nature.com/articles/leu2011304 
|
| Verfasserangaben: | W. Wiktor-Jedrzejczak, C. Dearden, L. de Wreede, A. van Biezen, L. Brinch, V. Leblond, M. Brune, L. Volin, M. Kazmi, A. Nagler, J. Schetelig, T. de Witte and P. Dreger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1575021919 | ||
| 003 | DE-627 | ||
| 005 | 20230427042900.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180514r20122011xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2011.304 |2 doi | |
| 035 | |a (DE-627)1575021919 | ||
| 035 | |a (DE-576)505021919 | ||
| 035 | |a (DE-599)BSZ505021919 | ||
| 035 | |a (OCoLC)1341009565 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jędrzejczak, Wiesław |d 1947- |e VerfasserIn |0 (DE-588)1158308531 |0 (DE-627)1067696121 |0 (DE-576)503755583 |4 aut | |
| 245 | 1 | 0 | |a Hematopoietic stem cell transplantation in T-prolymphocytic leukemia |b a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium |c W. Wiktor-Jedrzejczak, C. Dearden, L. de Wreede, A. van Biezen, L. Brinch, V. Leblond, M. Brune, L. Volin, M. Kazmi, A. Nagler, J. Schetelig, T. de Witte and P. Dreger |
| 264 | 1 | |c 2012 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 25 November 2011 | ||
| 500 | |a Gesehen am 14.05.2018 | ||
| 520 | |a T-prolymphocytic leukemia (T-PLL) has a very poor prognosis with conventional immunochemotherapy. Incidental reports suggest that allogeneic hematopoietic stem cell transplantation (allo-HSCT) might have a role in this disease. Therefore, the purpose of the present study was to analyze the outcome of transplants for T-PLL registered with the European Group for Blood and Marrow Transplantation database and the Royal Marsden Consortium. Eligible were 41 patients with a median age of 51 (24-71) years; median time from diagnosis to treatment was 12 months, and in complete remission (CR) (11), partial remission (PR) (12), stable or progressive disease (13) and unknown in 5 patients. A total of 13 patients (31%) received reduced-intensity conditioning. Donors were HLA-identical siblings in 21 patients, matched unrelated donors in 20 patients. With a median follow-up of surviving patients of 36 months, 3-year relapse-free survival (RFS) and OS was 19% (95% CI, 6-31%) and 21% (95% CI, 7-34%), respectively. Multivariate analysis identified TBI and a short interval between diagnosis and HSCT as factors associated with favorable RFS. Three-year non relapse mortality and relapse incidence were each 41% with the majority of relapses occurring within the first year. These data indicate that allo-HSCT may provide effective disease control in selected patients with T-PLL. | ||
| 534 | |c 2011 | ||
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 26(2012), 5, Seite 972-976 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Hematopoietic stem cell transplantation in T-prolymphocytic leukemia a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium |
| 773 | 1 | 8 | |g volume:26 |g year:2012 |g number:5 |g pages:972-976 |g extent:5 |a Hematopoietic stem cell transplantation in T-prolymphocytic leukemia a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/leu.2011.304 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/leu2011304 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180514 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 13 |y j | ||
| 999 | |a KXP-PPN1575021919 |e 3009264909 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Published online: 25 November 2011","Gesehen am 14.05.2018"],"relHost":[{"recId":"32046699X","origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"disp":"Hematopoietic stem cell transplantation in T-prolymphocytic leukemia a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden ConsortiumLeukemia","note":["Gesehen am 15.03.04"],"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"part":{"volume":"26","year":"2012","text":"26(2012), 5, Seite 972-976","pages":"972-976","extent":"5","issue":"5"},"language":["eng"],"pubHistory":["Nachgewiesen 11.1997 -"]}],"physDesc":[{"extent":"5 S."}],"id":{"doi":["10.1038/leu.2011.304"],"eki":["1575021919"]},"recId":"1575021919","origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Wiesław","role":"aut","display":"Jędrzejczak, Wiesław","family":"Jędrzejczak"},{"role":"aut","given":"Peter","display":"Dreger, Peter","family":"Dreger"}],"name":{"displayForm":["W. Wiktor-Jedrzejczak, C. Dearden, L. de Wreede, A. van Biezen, L. Brinch, V. Leblond, M. Brune, L. Volin, M. Kazmi, A. Nagler, J. Schetelig, T. de Witte and P. Dreger"]},"language":["eng"],"title":[{"title_sort":"Hematopoietic stem cell transplantation in T-prolymphocytic leukemia","subtitle":"a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium","title":"Hematopoietic stem cell transplantation in T-prolymphocytic leukemia"}]} | ||
| SRT | |a JEDRZEJCZAHEMATOPOIE2012 | ||